Grant

A Phase 3, Open-Label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly Mod-4023 Compared to Daily Genotropin - Therapy in Pre-Pubertal Children with Growth Hormone Deficiency

Sponsored by Clinical Professionals, Inc

$63.3K Funding

1 People

External

Related Topics

growth hormone deficiency, efficacy, safety, pediatric endocrinology, clinical trial

People

Cindy Chin
Principal Investigator (PI)
Pediatrics﹒Clinical Associate Professor